Association between smoking, nicotine dependence, and BDNF Val66Met polymorphism with BDNF concentrations in serum

Nicotine and Tobacco Research

Volumn 17, Issue 3, 2015, Pages 323-329

  Jamal, Mumtaz ^a   Van der Does, Willem ^a,b   Elzinga, Bernet M ^a   Molendijk, Marc L ^a   Penninx, Brenda W J H ^b,c,d  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; VALINE; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN; METHIONINE;

ADULT; ARTICLE; CONTROLLED STUDY; FAGERSTROM TEST FOR NICOTINE DEPENDENCE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MALE; NETHERLANDS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING; TOBACCO DEPENDENCE; BLOOD; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; GENETICS; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; TOBACCO USE DISORDER;

ADULT; BRAIN-DERIVED NEUROTROPHIC FACTOR; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HUMANS; MALE; METHIONINE; MIDDLE AGED; NETHERLANDS; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; SMOKING; TOBACCO USE DISORDER; VALINE;

EID: 84939437088     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntu151     Document Type: Article

References (66)

1. Leibrock J, Lottspeich F, Hohn A, et al. Molecular cloning and expression of brain-derived neurotrophic factor. Nature. 1989;341:149-152.
2. Conner JM, Lauterborn JC, Yan Q, Gall CM, Varon S. Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J Neurosci. 1997;17:2295-2313. Retrieved from http://www.jneurosci.org/content/17/7/2295.full.pdf+html.
3. KatohSemba R, Takeuchi IK, Semba R, Kato K. Distribution of brainderived neurotrophic factor in rats and its changes with development in the brain. J Neurochem. 1997;69:34-42.
4. Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci. 2001;24:677-736.
5. Park H, Poo M-M. Neurotrophin regulation of neural circuit development and function. Nat Rev Neurosci. 2013;14:7-23.
6. Mossner R, Daniel S, Albert D, et al. Serotonin transporter function is modulated by brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF). Neurochem Int. 2000;36:197-202.
7. Hyman C, Hofer M, Barde YA, et al. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature. 1991;350:230-232.
8. Carvalho AL, Caldeira MV, Santos SD, Duarte CB. Role of the brainderived neurotrophic factor at glutamatergic synapses. Br J Pharmacol. 2008;153:S310-S324.
9. Paredes D, Granholm AC, Bickford PC. Effects of NGF and BDNF on baseline glutamate and dopamine release in the hippocampal formation of the adult rat. Brain Res. 2007;141:56-64.
10. Pascual M, Climent E, Guerri C. BDNF induces glutamate release in cerebrocortical nerve terminals and in cortical astrocytes. Neuroreport. 2001;12:2673-2677.
11. Korte M, Carroll P, Wolf E, Brem G, Thoenen H, Bonhoeffer T. Hippocampal long-term potentiation is impaired in mice lacking brainderived neurotrophic factor. Proc Natl Acad Sci USA. 1995;92:8856-8860.
12. Fujimura H, Altar CA, Chen RY, et al. Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. J Thromb Haemost. 2002;87:8-734.
13. Pliego Rivero FB, Bayatti N, Giannakoulopoulos X, et al. Brainderived neurotrophic factor in human platelets. Biochem Pharmacol. 1997;54:207-209.
14. Yamamoto H, Gurney ME. Human platelets contain brain-derived neurotrophic factor. J Neurosci. 1990;10:3469-3478.
15. Radka SF, Holst PA, Fritsche M, Altar CA. Presence of brain-derived neurotrophic factor in brain in human and rat but not mouse serum detected by a sensitive and specific immunoassay. Brain Res. 1996;709:122-130.
16. Rosenfeld RD, Zeni L, Haniu N, et al. Purification and identification of brain-derived neurotrophic factor from human serum. Protein Express Purif. 1995;6:465-471.
17. Karege F, Schwald M, Cisse M. Postnatal developmental profile of brainderived neurotrophic factor in rat brain and platelets. Neurosci Lett. 2002;328:261-264.
18. Maisonpierre PC, Lebeau MM, Espinosa R, et al. Human and rat brainderived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations. Genomics. 1991;10:558-568.
19. Bath KG, Lee FS. Variant BDNF (Val66Met) impact on brain structure and function. Cogn Affect Behav Neurosci. 2006;6:79-85.
20. Guillin O, Diaz J, Carroll P, Griffon N, Schwartz JC, Sokoloff P. BDNF controls dopamine D-3 receptor expression and triggers behavioural sensitization. Nature. 2001;411:86-89.
21. Janhunen S, Ahtee L. Differential nicotinic regulation of the nigrostriatal and mesolimbic dopaminergic pathways: implications for drug development. Neurosci Behav Rev. 2007;31:287-314.
22. Kenny PJ, File SE, Neal MJ. Evidence for a complex influence of nicotinic acetylcholine receptors on hippocampal serotonin release. J Neurochem. 2000;75:2409-2414.
23. Seth P, Cheeta S, Tucci S, File SE. Nicotinic-serotonergic interactions in brain and behaviour. Pharmacol Biochem Behav. 2002; 71:795-805.
24. Touiki K, Rat P, Molimard R, Chait A, de Beaurepaire R. Effects of tobacco and cigarette smoke extracts on serotonergic raphe neurons in the rat. Neuroreport. 2007;18:925-929.
25. Zhang L, Dong Y, Doyon WM, Dani JA. Withdrawal from chronic nicotine exposure alters dopamine signaling dynamics in the nucleus accumbens. Biol Psychiatry. 2012;71:184-191.
26. Ribeiro EB, Bettiker RL, Bogdanov M, Wurtman RJ. Effects of systemic nicotine on serotonin release in rat brain. Brain Res. 1993;621:311-318.
27. Ehara Watanabe MA, Vargas Nunes SO, Amarante MK, et al. Genetic polymorphism of serotonin transporter 5-HTTLPR: involvement in smoking behaviour. J Genet. 2011;90:179-185.
28. Hu S, Brody CL, Fisher C, et al. Interaction between the serotonin transporter gene and neuroticism in cigarette smoking behavior. Mol Psychiatry. 2000;5:181-188.
29. Ishikawa H, Ohtsuki T, Ishiguro H, et al. Association between serotonin transporter gene polymorphism and smoking among Japanese males. Cancer Epidemiol Biomarkers Prev. 1999;8:831-833.
30. Kremer I, Bachner-Melman R, Reshef A, et al. Association of the serotonin transporter gene with smoking behavior. Am J Psychiatry. 2005;162:924-930.
31. Andresen JH, Loberg EM, Wright M, et al. Nicotine affects the expression of brain-derived neurotrophic factor mRNA and protein in the hippocampus of hypoxic newborn piglets. J Perinatal Med. 2009;37: 553-560.
32. Kenny PJ, File SE, Rattray M. Acute nicotine decreases, and chronic nicotine increases the expression of brain-derived neurotrophic factor mRNA in rat hippocampus. Mol Brain Res. 2000;85:234-238.
33. Zhang XY, Xiu MH, Chen DC, et al. Nicotine dependence and serum BDNF levels in male patients with schizophrenia. Psychopharmacology. 2010;212:301-307.
34. Bus BAA, Molendijk ML, Penninx BJWH, et al. Determinants of serum brain-derived neurotrophic factor. Psychoneuroendocrinology. 2011;36:228-239.
35. Lang UE, Sander T, Lohoff FW, et al. Association of the Met66 allele of brain-derived neurotrophic factor (BDNF) with smoking. Psychopharmacology. 2007;190:433-439.
36. Wang ZR, Zhou DF, Cao LY, et al. Brain-derived neurotrophic factor polymorphisms and smoking in schizophrenia. Schizophr Res. 2007;97:299-301.
37. Montag C, Basten U, Stelzel C, Fiebach CJ, Reuter M. The BDNF Val66Met polymorphism and smoking. Neuroscience Lett. 2008;442:30-33.
38. Brunoni AR, Lopes M, Fregni F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol. 2008;11:1169-1180.
39. Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry. 2006;59:1116-1127.
40. Sen S, Duman R, Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry. 2008;64:527-532.
41. Ströhle A, Stoy M, Graetz B, et al. Acute exercise ameliorates reduced brain-derived neurotrophic factor in patients with panic disorder. Psychoneuroendocrinology. 2010;35:364-368.
42. Cosci F, Knuts IJE, Abrams K, Griez EJL, Schruers KRJ. Cigarette smoking and panic: a critical review of the literature. J Clin Psychiatry. 2010;71:606-615.
43. Covey LS, Glassman AH, Stetner F. Cigarette smoking and major depression. J Addict Dis. 1998;17:35-46.
44. Morrell HER, Cohen LM. Cigarette smoking, anxiety, and depression. J Psychopathol Behavior Assess. 2006;28:283-297.
45. Zvolensky MJ, Feldner MT, Leen-Feldner EW, McLeish AC. Smoking and panic attacks, panic disorder, and agoraphobia: a review of the empirical literature. Clin Psychol Rev. 2005;25:761-789.
46. Penninx BWJH, Beekman ATF, Smit JH, et al. The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods. Int J Methods Psychiatric Res. 2008;17:121-140.
47. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom K-O. The Fagerström test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addict. 1991;86:1119-1127.
48. Pomerleau CS, Carton SM, Lutzke ML, Flessland KA, Pomerleau OF. Reliability of the Fagerstrom tolerance questionnaire and the Fagerstrom test for nicotine dependence. Addict Behav. 1994;19:33-39.
49. Burling AS, Burling TA. A comparison of self-report measures of nicotine dependence among male drug/alcohol-dependent cigarette smokers. Nicotine Tob Res. 2003;5:625-633.
50. Pedersen W, von Soest T. Smoking, nicotine dependence and mental health among young adults: a 13-year population-based longitudinal study. Addiction. 2009;104:129-137.
51. Wittchen H-U, Robins LN, Cottler LB, Sartorius N, Burke JD, Regier D. Cross-cultural feasibility, reliability, and sources of variance of the composite international diagnostic interview (CIDI): the multicentre WHO/ADAMHA field trials. Br J Psychiatry. 1991;159:645-653.
52. Babor TF, Kranzler HR, Lauerman RJ. Early detection of harmful alcohol consumption: comparison of clinical, laboratory, and self-report screening procedures. Addict Behav. 1989;14:139-157.
53. Craig CL, Marshall AL, Sjostrom M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381-1395.
54. Brugha T, Bebbington P, Tennant C, Hurry J. The list of threatening experiences: a subset of 12 life event categories with considerable long-term contextual threat. Psychol Med. 1985;15:189-194.
55. Molendijk ML, Bus BAA, Spinhoven P, et al. Serum levels of brainderived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment. Mol Psychiatry. 2011;16:1088-1095.
56. Huang T, Larsen KT, Ried-Larsen M, Moller NC, Andersen LB. The effects of physical activity and exercise on brain-derived neurotrophic factor in healthy humans: a review. Scand J Med Sci Sports. 2014;24: 1-10.
57. Lommatzsch M, Zingler D, Schuhbaeck K, et al. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging. 2005;26:115-123.
58. Zanardini R, Fontana A, Pagano R, et al. Alterations of brain-derived neurotrophic factor serum levels in patients with alcohol dependence. Alcohol Clin Exp Res. 2011;35:1529-1533.
59. Boomsma DI, Willemsen G, Sullivan PF, et al. Genome-wide association of major depression: description of samples for the GAIN major depressive disorder study: NTR and NESDA biobank projects. Eur J Hum Genet. 2008;16:335-342.
60. Colzato LS, Van der Does AJW, Kouwenhoven C, Elzinga BM, Hommel B. BDNF Val66Met polymorphism is associated with higher anticipatory cortisol stress response, anxiety, and alcohol consumption in healthy adults. Psychoneuroendocrinology. 2011;36:1562-1569.
61. Kenny PJ, Cheeta S, File SE. Anxiogenic effects of nicotine in the dorsal hippocampus are mediated by 5-HT1A and not by muscarinic M-1 receptors. Neuropharmacology. 2000;39:300-307.
62. Umene-Nakano W, Yoshimura R, Yoshii C, et al. Varenicline does not increase serum BDNF levels in patients with nicotine dependence. Hum Psychopharmacol Clin Exp. 2010;25:276-279.
63. Molendijk ML, Bus BAA, Spinhoven P, et al. Gender-specific associations of serum levels of brain-derived neurotrophic factor in anxiety. World J Biol Psychiatry. 2012;13:535-543.
64. Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry. 2003;60:804-815.
65. Roceri M, Hendriks W, Racagni G, Ellenbroek BA, Riva MA. Early maternal deprivation reduces the expression of BDNF and NMDA receptor subunits in rat hippocampus. Mol Psychiatry. 2002;7:609-616.
66. Smith MA, Makino S, Kvetňanský R, Post RM. Effects of stress on neurotrophic factor expression in the rat brain. Ann N Y Acad Sci. 1995;771:234-239.